Filing Details
- Accession Number:
- 0001209191-16-134691
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-01 17:37:21
- Reporting Period:
- 2016-07-28
- Filing Date:
- 2016-08-01
- Accepted Time:
- 2016-08-01 17:37:21
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1524472 | Xylem Inc. | XYL | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1226924 | R Steven Loranger | 1 International Drive C/O Xylem Inc. Rye Brook NY 10573 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-07-28 | 32,246 | $30.03 | 38,334 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-07-28 | 32,246 | $48.01 | 6,088 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-07-28 | 32,246 | $0.00 | 32,246 | $30.03 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 100,019 | 2018-10-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 80,367 | Indirect | By Steven R. Loranger Revocable Trust |
| Common Stock | 50,551 | Indirect | By Betsy Palmer Loranger Revocable Trust |
Footnotes
- The exercise and sale was made under a 10b5-1 plan adopted by the reporting person on June 1, 2016.
- This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $48.00 to $48.05 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission Staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
- 6,500 Shares previously reported as directly held, were transferred to the Steven R. Loranger Revocable Trust in transactions exempt from reporting under 16a-13.
- These options are fully vested and exercisable.
Billionaire Hedge Funds
